Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry

BACKGROUND: In a previous study, a proteomic panel consisting of BCL-2, HER2, CD133, CAIX, and ERCC1 significantly predicted survival in patients with locally advanced cervical cancer. However, the prognostic significance of these proteins has not been assessed in early cervical cancer. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soo Young, Chung, Joon-Yong, Byeon, Sun-Ju, Kim, Chul Jung, Lee, Yoo-Young, Kim, Tae-Joong, Lee, Jeong-Won, Kim, Byoung-Gie, Chae, Ye Lin, Oh, So Young, Choi, Chel Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327183/
https://www.ncbi.nlm.nih.gov/pubmed/34350111
http://dx.doi.org/10.3389/fonc.2021.665595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327183/
https://www.ncbi.nlm.nih.gov/pubmed/34350111
http://dx.doi.org/10.3389/fonc.2021.665595

Ejemplares similares